Par Pharmaceutical, Inc. et al v. Takeda Pharmaceutical Co., Ltd. et al

Filing 19

Order by Hon. Lucy H. Koh granting 17 Stipulated Extension to Answer Complaint.(lhklc2, COURT STAFF) (Filed on 5/28/2013)

Case5:13-cv-01927-LHK Document17 Filed05/22/13 Page1 of 4

1 Parties and counsel listed on Signature Page
2
3
4
5
6
7
8

UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA

9
PAR PHARMACEUTICAL, INC., AND
10 HANDA PHARMACEUTICALS, LLC.,

Case No. 5:13-cv-1927 LHK

11

Plaintiffs,

12

v.

STIPULATED EXTENSION TO ANSWER
THE COMPLAINT; [PROPOSED] ORDER
THEREON [1]

13 TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
14 AMERICA, INC., TAKEDA
PHARMACEUTICALS AMERICA, INC.,
15 AND TAKEDA PHARMACEUTICALS
U.S.A., INC.,
16
Defendants.
17

Hon. Lucy H. Koh, U.S.D.J.

18
19
20
21
22
23
24
25
26
27
28
20849371.2

CASE NO. 5:13-CV-1927 LHK
STIPULATED EXTENSION OF TIME TO ANSWER COMPLAINT

Case5:13-cv-01927-LHK Document17 Filed05/22/13 Page2 of 4

1

Plaintiffs Handa Pharmaceuticals, LLC, and Par Pharmaceuticals, Inc., (collectively,

2 “Handa/Par”) and Defendants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals
3 U.S.A., Inc., and Takeda Pharmaceuticals America, Inc. (collectively, “Takeda”), through counsel,
4 jointly request an order from the Court adopting the parties’ agreement related to the time for
5 Takeda to respond to the Complaint in this action.
6

WHEREAS, in an effort of cooperation, the parties have discussed and come to an

7 agreement on issues relating to an extension of time for Takeda to respond to the Complaint;
8

WHEREAS, this is the first extension of time requested in this action; and

9

WHEREAS, the requested extension will have no prejudicial effect on the schedule for this

10 case.
11

IT IS HEREBY STIPULATED AND AGREED, subject to the approval of the Court, that:

12

1.

Takeda’s Answer to the Complaint in this action shall be filed with this Court no

13 later than May 29, 2013.
14
15 DATED: May 22, 2013

PAR PHARMACEUTICAL, INC. AND
HANDA PHARMACEUTICALS, LLC

16
17
By:
/s/ Mark T. Jansen
Mark T. Jansen (SBN 114896)
[e-mail]
CROWELL & MORING LLP
275 Battery St., 23rd Fl.
San Francisco, CA 94111
Telephone: [phone]
Facsimile: [phone]

18
19
20
21
22
23

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS AMERICA, INC., AND
TAKEDA PHARMACEUTICALS U.S.A., INC.

24
25
26
27
28
20849371.2

By:
/s/ Heather E. Takahashi
Jeffrey I. Weinberger (SBN 056214)
[e-mail]
CASE NO. 5:13-CV-1927 LHK
-2STIPULATED EXTENSION OF TIME TO ANSWER COMPLAINT

Case5:13-cv-01927-LHK Document17 Filed05/22/13 Page3 of 4

1

Ted G. Dane (SBN 143195)
[e-mail]
Heather E. Takahashi (SBN 245845)
[e-mail]
Ryan N. Hagglund (pro hac vice)
[e-mail]
MUNGER, TOLLES & OLSON LLP
355 South Grand Avenue, 35th Floor
Los Angeles, CA 90071-1560
Telephone: [phone]
Facsimile:
[phone]

2
3
4
5
6
7

8 PURSUANT TO STIPULATION, IT IS SO ORDERED.
May 28
9 Dated: _____________, 2013
10
11
12

THE HONORABLE LUCY H. KOH
UNITED STATES DISTRICT JUDGE

13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
20849371.2

CASE NO. 5:13-CV-1927 LHK
-3STIPULATED EXTENSION OF TIME TO ANSWER COMPLAINT